Arginine Polymerization Boosts Anti‐Inflammatory Effects and DNA Nanostructure‐Assisted siRNA Delivery in Acute Respiratory Distress Syndrome
Small · 2026
DOI: 10.1002/smll.202511807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Boxuan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Xinqiao Hospital of Third Military Medical University (Army Medical University), Chongqing, Chi…. Hauptthemen laut MEDLINE: RNA, Small Interfering, DNA Nanostructures, Arginine, Anti-Inflammatory Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing, Key Project of Chongqing, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Severe lung inflammation and acute respiratory distress syndrome (ARDS) represent one of the most life‐threatening conditions in critical care units and no effective drugs are available clinically. Here, we show that the polymerization of arginine greatly boosts the anti‐inflammatory effect of arginine in vitro. RNA transcription sequencing and analysis indicated that polyarginine upregulated the expression of the anti‐inflammatory cytokine IL‐4. Meanwhile, polyarginine can assemble DNA nanostructures in a magnesium‐free manner and enhance the cellular uptake of DNA due to its cell‐penetrating nature, thereby boosting DNA nanostructure‐based drug delivery efficiency. To validate the potential of polyarginine as an anti‐inflammation prodrug, an arginine trimer (3R) assembled DNA nanotube that carries p65 siRNA (NT 3R ‐p65) was assembled as a model nanomedicine for ARDS therapy. Flow cytometry results showed polyarginine‐assembled DNA nanotubes exhibited higher cellular uptake efficiencies than the magnesium‐assembled counterpart. Most importantly, NT 3R ‐p65 effectively suppressed lung inflammatory in vitro and in ARDS mouse models. Mechanistically, 3R suppresses phosphorylated p65 expression and upregulates IL‐4 signaling pathway while p65 siRNA directly silencing p65 expression. The prodrug 3R and p65 siRNA exhibited additive anti‐inflammation effects in vitro and vivo. Collectively, the prodrug and gene therapy combination might offer a potential strategy for treating ARDS or other severe lung inflammation‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Xinqiao Hospital of Third Military Medical University (Army Medical University), Chongqing, China.
- Department of Pharmacy, Changzhi Medical College, Changzhi, Shanxi, China.
- Chongqing Key Laboratory of Precision Medicine and Prevention of Major Respiratory Diseases, Chongqing, China.
- Laboratory of Pharmacy and Chemistry, and Laboratory of Tissue and Cell Biology, Lab Teaching & Management Center, Chongqing Medical University, Chongqing, China.
- Yu-Yue Pathology Scientific Research Center, Chongqing, China.
ORCID-Profile: Hang Qian
Förderung
- Natural Science Foundation of Chongqing
- Key Project of Chongqing
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Li, B., Huang, C., Dang, W., Liu, Q., Wang, B., Wang, L., You, Q., He, B., Zhang, M., Liu, G., Wang, G., Xu, Z., & Qian, H. (2026). Arginine Polymerization Boosts Anti‐Inflammatory Effects and DNA Nanostructure‐Assisted siRNA Delivery in Acute Respiratory Distress Syndrome. Small. https://doi.org/10.1002/smll.202511807
Vancouver
Li B, Huang C, Dang W, Liu Q, Wang B, Wang L, et al. Arginine Polymerization Boosts Anti‐Inflammatory Effects and DNA Nanostructure‐Assisted siRNA Delivery in Acute Respiratory Distress Syndrome. Small. 2026. doi:10.1002/smll.202511807
BibTeX
@article{Li2026,
author = {Li, Boxuan and Huang, Chaowang and Dang, Wentao and Liu, Qian and Wang, Bin and Wang, Lu and You, Qianyi and He, Binfeng and Zhang, Mingzhou and Liu, Gang and Wang, Guansong and Xu, Zhi and Qian, Hang},
title = {Arginine Polymerization Boosts Anti‐Inflammatory Effects and DNA Nanostructure‐Assisted siRNA Delivery in Acute Respiratory Distress Syndrome},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202511807}
}
EUVIMED